UA-145931898-1

Top Selling Biologics Market - Current Market Landscape

Comments · 218 Views

The “Top Selling Biologics Market, report features an extensive study of the current market landscape and future potential of the top selling biologics available for the treatment of a variety of disease indications.

As of today, most of the top revenue generating drugs, across the globe, are biologics. During our biologics market research, we were able to identify 67 top selling biologics (revenues equal to or above USD 500 million in 2020). Top selling biologics market has so far been primarily led by industry players. Majority of industry players have taken a step towards investing their time and resources for the development of biologic therapies. Genentech, Amgen, Janssen Biotech, Sanofi and Novo Nordisk are amongst the major players in this domain. Biogen, AstraZeneca, Merck, Bristol Myers Squibb, GlaxoSmithKline, Alexion Pharmaceuticals, AbbVie and Novartis are other players that have entered the Top Selling Biologics domain in the past.

 

To request a sample report: https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html

 

It is worth highlighting that most of the therapies are monoclonal antibodies capture the highest share (54%) of the top selling biologics market. This can be attributed to the various advantages offered by them, including high reproducibility and specificity. It is also worth mentioning that these therapeutic modalities are being used for many cancer indications. Further, most of the top selling biologics are currently delivered via subcutaneous route of administration. However, most of the top selling biologics are available in the form of vials. This can be attributed to the better sterility assurance and reduced particle presence offered by such packaging formats.

 

To order customize report: https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-customization.html

 

It is worth highlighting that most of the therapies are being developed against autoimmune and oncological disorders; Oncological indications targeted by biologics include colorectal cancer (6), Non-Small Cell Lung Cancer (3), Breast Cancer (3), Hepatocellular Carcinoma (3), bladder cancer (3), urothelial carcinoma (3), and melanoma (3).

 

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/top-selling-biologics-market.html

 

You may also be interested in the following reports:

  1. Antibody Drug Conjugates Market
  2. Cell and Gene Therapy CROs Market
  3. Bispecific Antibody Therapeutics Market
  4. Genome Editing Services Market

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

 

 

The site management organizations (SMO) market is projected to grow at an annualized rate of ~10% during the period 2021-2035, claims Roots Analysis

 

The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented lucrative opportunities for service providers with expertise in clinical trial site management

 

Roots Analysis has announced the addition of “Site Management Organizations (SMO) Market, 2021 – 2035” report to its list of offerings

 

In recent years, drug / device developers have demonstrated a preference to continue relying on SMOs for conducting clinical trials in order to significantly optimize trial cost and research timelines. Driven by the steady growth in clinical research activity and inherent benefits offered by Site management organizations (SMO), the market opportunity for such players is projected to grow at a significant pace in the foreseen future.

 

To order this 270+ page report, which features 95+ figures and 120+ tables, please visit

https://www.rootsanalysis.com/reports/site-management-organizations-market.html

 

 

 

Key Market Insights

 

Around 250 companies across the world claim to offer clinical trial site management services

Majority (43%) of the industry stakeholders are headquartered in North America, followed by those based in Asia-Pacific (32%) and Europe (19%). In addition, 25% of the companies engaged in this domain offer site management services across the globe, followed by those providing services in Asia-Pacific (23%).

 

200+ partnerships were established in this domain, during the period 2016-2021

Service alliances (26%) and clinical trial agreements (23%) emerged as the most common types of partnership models adopted by stakeholders engaged in this domain. Nearly 65% of the deals in this domain were established after 2018, with the maximum activity being reported in 2021 (56).

 

~USD 1 billion invested in various domain focused initiatives, since 2015

Maximum number of funding instances (21%) were reported in 2021, amounting to USD 614 million in capital investments. A significant number of funding instances (43%) were venture capital rounds, followed by instances of other equity (29%) and grants (7%).

 

Till 2035, annual demand for clinical trial study participants is expected grow at a CAGR of 8.2%

Currently, North America and Asia-Pacific hold the majority share of the overall demand for clinical trial study participants (60%). By 2035, the demand for patients in clinical trial studies is projected to reach 25 million. Further, currently, the highest demand is generated via phase III trials (43%), followed by phase IV studies (38%).

 

North America and Europe are anticipated to capture close to 65% of the market share, by 2035

In addition, in Asia-Pacific the Site Management Organization Market Growth is likely to be at a relatively faster pace (9%) in the long term. Further, in 2035, the majority share (~45%) of clinical trial site management revenues is likely to be generated from trials focused on phase III evaluation of clinical studies.

 

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/site-management-organizations-market/request-sample.html

 

 

Key Questions Answered

  • Who are the leading players engaged in the clinical trial site management domain?
  • What is the relative competitiveness of different site management organizations?
  • What type of partnership models are commonly adopted by stakeholders in this industry?
  • What is the capital investments trend in the site management organizations domain?
  • Which are the most active clinical trial centers?
  • What are the major market trends and driving factors that are likely to impact the growth of site management organizations market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

 

The financial opportunity within the SMOs market has been analyzed across the following segments:

 

  • Therapeutic Areas
  • Oncological Disorders
  • CNS Disorders
  • Infectious Diseases
  • Respiratory Disorders
  • Cardiovascular Diseases
  • Endocrine Disorders
  • Gastrointestinal Disorders
  • Musculoskeletal Diseases
  • Immunological Disorders
  • Others

 

  • Trial Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

 

  • Clinical Trial Components
  • Site Management
  • Onsite Monitoring
  • Project Management
  • Data Management
  • Regulatory Affairs
  • Logistics
  • Quality Control
  • Others

 

  • Types of Interventions
  • Therapeutics
  • Devices
  • Surgical Procedure

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MENA
  • Rest of the World 

 

The report also features inputs from eminent industry stakeholders, according to whom, complexities associated with clinical trial processes and increasing clinical pipeline will drive the growth of the third-party service providers, such as SMOs, engaged in this domain, in the coming future. The report includes detailed transcripts of discussions held with the following experts:

 

The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its site management service portfolio, recent developments and an informed future outlook.

  • FOMAT Medical Research
  • Parexel
  • Pharm-Olam
  • Veristat
  • WCCT Global
  • Worldwide Clinical Trials
  • CROMSOURCE
  • Fidelis Research
  • Scandinavian CRO
  • TFS HealthScience
  • Trialbee
  • CMIC
  • George Clinical
  • Tigermed
  • Veeda Clinical Research

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/site-management-organizations-market.html

or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

  1. Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
  2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
  3. Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030
  4. Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
  5. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Comments